Our governance structure has been established to ensure appropriate management of strategic priorities, robust financial management, content expertise, and clear communication across all partner organisations.
Chaired by Prof Brian Schmidt, Vice Chancellor and President of The Australian National University, our Independent Advisory Board works in conjunction with the National Steering Committee to advocate for Australian Genomics. The Board provides independent, strategic advice, identifies national and international industry partnership opportunities and supports health policy and implementation opportunities for our research outcomes into the health system.
The National Steering Committee is responsible for managing the scope of the research program and ensuring sound financial management. The Committee is comprised of leads from our research programs and clinical flagships, and representative of the founding institutions who conceived of Australian Genomics and contributed to the initial submission to the National Health and Medical Research Council Targeted Call for genomics research. They meet quarterly to review the progress of the research programs and allocate resources.
The National Implementation Committee works in conjunction with the National Steering Committee to inform appropriate strategies and facilitate the implementation of Australian Genomics research outcomes into the Australian health system. Members of the Committee apply their expertise in health system planning, policy development and translation. The Committee members and Australian Genomics share a commitment to ensure the efficient, effective, ethical and equitable implementation of genomic healthcare under Australia’s National Health Genomics Policy Framework.
The National Steering Committee works with International Advisors to bring international best practice to our work and provide opportunities for international collaboration. Our international advisors include representatives of the Global Alliance for Genomics and Health (GA4GH), the Global Genomic Medicine Collaborative (G2MC), Genomics England, National Human Genome Research Institute (NIH), Broad Institute, Genome Canada and Genome BC.
The Community Advisory Group brings together experienced patient advocates providing counsel on our research activity. The Group advises on the design and language of patient surveys, digital health and data management strategy, and ethical, legal and social analyses of genomics. The group is instrumental in the development of our online participant portal and Genomics in the Community initiatives.
The Committee provides both Australian Genomics and the Australian Digital Health Agency advice regarding the future development of Australia’s digital health foundations, supporting the advancement of precision medicine and other activities relating to the public good which are enabled by the integration of genomic information with health and related data.
The National Implementation Committee works with the National Steering Committee to provide advice on appropriate strategies and facilitate implementation. The committee is made up of policymakers and planners from federal and state health systems.